Gut-on-a-chip models for dissecting the gut microbiology and physiology

Abstract

Microfluidic technologies have been extensively investigated in recent years for developing organ-on-a-chip-devices as robust in vitro models aiming to recapitulate organ 3D topography and its physicochemical cues. Among these attempts, an important research front has focused on simulating the physiology of the gut, an organ with a distinct cellular composition featuring a plethora of microbial and human cells that mutually mediate critical body functions. This research has led to innovative approaches to model fluid flow, mechanical forces, and oxygen gradients, which are all important developmental cues of the gut physiological system. A myriad of studies has demonstrated that gut-on-a-chip models reinforce a prolonged coculture of microbiota and human cells with genotypic and phenotypic responses that closely mimic the in vivo data. Accordingly, the excellent organ mimicry offered by gut-on-a-chips has fueled numerous investigations on the clinical and industrial applications of these devices in recent years. In this review, we outline various gut-on-a-chip designs, particularly focusing on different configurations used to coculture the microbiome and various human intestinal cells. We then elaborate on different approaches that have been adopted to model key physiochemical stimuli and explore how these models have been beneficial to understanding gut pathophysiology and testing therapeutic interventions.

Untangling Complexity: Gut Microbiota, Metabolites, and Fiber Intake in Type 2 Diabetes

“…Such approaches are still under development but may offer an in vitro alternative. 6,7 The combination of this innovative technology with advanced metabolomics and metagenomics has the potential to revolutionize ex vivo investigations, especially in scenarios that are challenging to study in vivo, paving the way for controlled experimentation that can gain insights into the intricate dynamics of the human gut microbiota. Moreover, this technology holds promise for advancing personalized medicine approaches, for example, by utilizing patient samples for testing medication responses.…”

Establishment and evaluation of on-chip intestinal barrier biosystems based on microfluidic techniques

“…Photolithography involves shining light onto light-sensitive materials (e.g., photoresist) coating a hard substrate (silicon or glass) to create patterned mold surface [ 103 ]. A typical photolithography process consists of several steps [ 104 , 105 ]. First, a photomask with elaborate geometric patterns is drawn using AI software.…”

“…Gut microbes are involved in regulating a variety of host metabolic responses; producing metabolites that are critical to gut health, such as short-chain fatty acids; and metabolizing bile acids, steroids, bile acids, choline, and other molecules [ 104 , 162 ]. In fact, some complex carbohydrates, such as dietary fiber, are digested by gut microbes and fermented at the proximal end of the colon to produce short-chain fatty acids, such as butyric acid, acetic acid, and propionic acid, which are known to have important neural activity [ 51 , 163 ].…”

Synthesis and Characterization of Hydroxyapatite Composite from Cuttlebone (Sepia sp.) with Chitosan via In Situ as Antibacterial

“…The bacteria often found in this problem are Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) and the fungi Blastomyces and Aspergillus. [1][2][3][4] Biomaterials such as metals, ceramics, polymers, and composites have been employed as bone implants. Hydroxyapatite (HAp), Ca 10 (PO 4 ) 6 (OH) 2 , one of the calcium phosphate family from ceramics, is preferred for use as bone implants because of its similar chemical composition to natural bones and teeth, good biocompatibility, bioactive, and osteoconductive properties.…”

“…However, using bone implants in orthopedics becomes a severe problem when a bone infection or osteomyelitis occurs, caused by biofilm formation by bacteria or fungi on the implant‘s surface. The bacteria often found in this problem are Escherichia coli ( E. coli ), Staphylococcus aureus ( S. aureus ) and the fungi Blastomyces and Aspergillus [1–4] …”